Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Tessera Technologies: The Money Keeps Rolling In. (Sound Familiar)

In lieu of "recurring revenues" it is my belief that we are getting future revenue streams (royalties) discounted to their present value, and taking that in lump sum (+ or - X, for "early movers"). In my book there is little difference.

The main difference as I see it is we have about 8 times the number of shares outstanding, which will always be an obstacle in getting to $30-$40.

Share
New Message
Please login to post a reply